CSPC Pharmaceutical Group Ltd
CSPC Pharmaceutical Group Ltd/ HK1093012172 /
1093
|
2024-09-20 10:08:30 AM
|
Chg.
+0.30
|
Volume |
Bid10:08:30 AM |
Ask10:08:30 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
4.99HKD
|
+6.40%
|
254.9 mill.
Turnover: 1.21 bill. |
4.98Bid Size: 492,000 |
4.99Ask Size: 1.18 mill. |
59.3 bill.HKD |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
0.49 CNY |
-3.21% |
| EPS Diluted: |
- CNY |
-3.21% |
| Revenues per Share: |
2.64 CNY |
1.92% |
| Book Value per Share: |
2.79 CNY |
10.23% |
| Cash Flow per Share: |
0.35 CNY |
-45.07% |
| Dividend per Share: |
0.28 CNY |
33.33% |
| Total |
in mill. |
|
| Revenues: |
31,450.11 CNY |
1.66% |
| Net Income: |
5,873.33 CNY |
-3.58% |
| Operating Cash Flow: |
4,178.82 CNY |
- |
| Cash and Cash Equivalents: |
12,015.22 CNY |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
9.13 |
16.58 |
| P/S Ratio: |
1.71 |
3.11 |
| P/BV ratio: |
1.62 |
2.94 |
| P/CF Ratio: |
12.87 |
23.37 |
| PEG: |
-2.85 |
-5.17 |
| Earnings Yield: |
10.95% |
6.03% |
| Dividend Yield: |
6.20% |
3.41% |
| Market Capitalization |
|
| Market Capitalization: |
59.3 bill. HKD |
109.94 bill. HKD |
| Free Float Market Cap.: |
- HKD |
- HKD |
| Market Cap. / Employee: |
2.52 mill. HKD |
4.68 mill. HKD |
| Shares Outstanding: |
11.9 bill. |
|
Profitability
| Gross Profit Margin: |
70.51% |
| EBIT Margin: |
0.00% |
| Net Profit Margin: |
18.68% |
| Return on Equity: |
17.69% |
| Return on Assets: |
12.69% |
Financial Strength
| Liquidity I / Cash Ratio: |
118.00% |
| Liquidity II / Quick Ratio: |
175.64% |
| Liquidity III / Current Ratio: |
262.65% |
| Debt / Equity Ratio: |
39.39% |
| Dynam. Debt / Equity Ratio: |
312.98% |
Efficiency
| Employees: |
23,500 |
| Personal Expenses / Employee: |
- CNY |
| Revenues / Employee: |
1,338,302.51 CNY |
| Net Income / Employee: |
249,928.72 CNY |
| Total Assets / Employee: |
1,969,454.04 CNY |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
HKFRS |
